Pulse Biosciences, Inc. (PLSE) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $51.70 (-6.82%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 20, 2026 | Suraj Kalia | Oppenheimer | $30.00 | -42.0% |
Top Analysts Covering PLSE
PLSE vs Sector & Market
| Metric | PLSE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +16.4% | +153002.0% | +21.5% |
| P/E Ratio | -20.21 | 3.49 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1M | $1M | $1M | 1 |
| 2027-03-31 | $2M | $2M | $2M | 1 |
| 2027-06-30 | $3M | $3M | $3M | 1 |
| 2027-09-30 | $4M | $4M | $4M | 1 |
| 2027-12-31 | $5M | $5M | $5M | 1 |
| 2028-12-31 | $35M | $41M | $47M | 1 |
| 2029-12-31 | $81M | $94M | $107M | 1 |
| 2030-12-31 | $152M | $178M | $203M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.35 | $-0.32 | $-0.28 | 1 |
| 2027-03-31 | $-0.47 | $-0.42 | $-0.37 | 1 |
| 2027-06-30 | $-0.47 | $-0.42 | $-0.37 | 1 |
| 2027-09-30 | $-0.48 | $-0.43 | $-0.38 | 1 |
| 2027-12-31 | $-0.48 | $-0.43 | $-0.38 | 1 |
| 2028-12-31 | $-0.94 | $-0.79 | $-0.64 | 1 |
| 2029-12-31 | $-0.37 | $-0.31 | $-0.25 | 1 |
| 2030-12-31 | $0.32 | $0.39 | $0.46 | 1 |
Frequently Asked Questions
What is the analyst consensus for PLSE?
The consensus among 3 analysts covering Pulse Biosciences, Inc. (PLSE) is Buy with an average price target of $53.20.
What is the highest price target for PLSE?
The highest price target for PLSE is $30.00, set by Suraj Kalia at Oppenheimer on 2026-02-20.
What is the lowest price target for PLSE?
The lowest price target for PLSE is $30.00, set by Suraj Kalia at Oppenheimer on 2026-02-20.
How many analysts cover PLSE?
3 analysts have issued ratings for Pulse Biosciences, Inc. in the past 12 months.
Is PLSE a buy or sell right now?
Based on 3 analyst ratings, PLSE has a consensus rating of Buy (2.00/5) with a +16.4% upside to the consensus target of $53.20.
What are the earnings estimates for PLSE?
Analysts estimate PLSE will report EPS of $-0.32 for the period ending 2026-12-31, with revenue estimated at $1M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.